Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,097 | 46,505 | -6,660 | 3,647 | 9,820 |
| Depreciation Amortization | 21,527 | 18,110 | 16,516 | 15,810 | 14,678 |
| Income taxes - deferred | -162 | 4,542 | -1,414 | 4,386 | -3,222 |
| Accounts receivable | -20,160 | 6,702 | -16,295 | -8,102 | 6,377 |
| Other Working Capital | 11,301 | -51,747 | 12,104 | 582 | 571 |
| Other Operating Activity | 43,663 | 17,650 | 33,940 | 22,886 | 10,336 |
| Operating Cash Flow | $57,266 | $41,762 | $38,191 | $39,209 | $38,560 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,146 | -8,815 | -217 | -2,895 | -632 |
| PPE Investments | -33,855 | -41,555 | -46,563 | -35,099 | -21,382 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -12,461 |
| Purchase Sale Intangibles | N/A | N/A | 4,400 | 2,000 | 0 |
| Other Investing Activity | -1,414 | -157 | 4,598 | 1,104 | -5,026 |
| Investing Cash Flow | $-36,415 | $-50,527 | $-42,182 | $-36,890 | $-39,501 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,521 | 3,570 | 8,778 | 18,983 | 10,198 |
| Debt Repayment | -8,401 | -6,781 | -5,705 | -9,712 | -14,652 |
| Common Stock Issued | 23,165 | 3,421 | 8,946 | 13,758 | 21,502 |
| Common Stock Repurchased | -24,425 | -22,291 | -25,047 | -30,747 | -9,908 |
| Other Financing Activity | -106 | 18,298 | 38,036 | 0 | 0 |
| Financing Cash Flow | $-2,246 | $-3,783 | $25,008 | $-7,718 | $7,140 |
| Exchange Rate Effect | 352 | -104 | -274 | 504 | 81 |
| Beginning Cash Position | 75,550 | 88,202 | 67,459 | 72,354 | 66,074 |
| End Cash Position | 94,507 | 75,550 | 88,202 | 67,459 | 72,354 |
| Net Cash Flow | $18,957 | $-12,652 | $20,743 | $-4,895 | $6,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,266 | 41,762 | 38,191 | 39,209 | 38,560 |
| Capital Expenditure | -33,855 | -41,555 | -46,808 | -35,099 | -21,382 |
| Free Cash Flow | 23,411 | 207 | -8,617 | 4,110 | 17,178 |